Trichomonas uaginalis, a pathogenic protozoa, i s ~ncapable of de novo purine synthesis and i s thus dependent on preformed purlnes Unltke other protozoa. T . uaginalis i s devotd of purine phosphoribosyltransfer act~vity but has both purine nucleoside phosphorylase (PNP) and purine nucleoside kinase act~vity. These enzymes comprise a potential route for the salvage of purlnes In this organism. Both enzymes have been purlfied and characterized.
of guanosine (11100).
adenosine (20011 11) and inosine (20167) . This enzyme appears to be the only purine ribonucleoside kinase activity in extracts of this organism.
The finding that both of these enzymes catalyze reactions involving the common purine nucleosides, guanosine and adenosine, suggests that they may act as a coordinated set of enzyme activities to salvage purines and purine ribonucleosides. 4'-Thioadenosine (4'-SAdo) is an adenosine analog with the bridge oxygen in the ribose replaced by a sulfur atom. 4'-SAdo is cytostatic to the HL-60 cells in concentrations-up to 25 VM after four days, within which the HL-60 cells can be induced to differentiate in a dose-dependent manner, as judged by their ability to reduce nitroblue tetrazolium. Uric acid binding to human plasma proteins has been studied in various physiological and paraphysiological conditions,including the following groups: I-a group of children aged 4-10 years; 2-a group of healthy males; 3-a group of subjects treated with estrogen preparations for prostatic cancer; 4-a group of regularly menstruating females with normal cycle; 5-a group of post-menopausal females; 6-a group of pregnant females; 7-a group of females treated with oral contraceptives; 8-a group of females treated with estrogen f reparations for post menopausal symptoms. The results obtained demonstrate a significant correlation between the increase of plasma estrogen and the increase of the uric acid binding to human plasma proteins. Procedures for the HPLC analysis of nucleosides and bases have generally been designed to fulfil specific requirements. No single method exists capable of separating all the purines and pyrimidines found in the biological fluids of patients in the different inherited disorders in a single run and within a reasonable time. Because of a need for such a system an appropriate method has been devised.
EFFECTS OF 4'-THIOADENOSINE
The system has been in continuous use for over two years and three to four thousand samples have been analysed. It has proved reliable and reproducible throughout the life of many columns. Problems encountered during this period have resulted from artifacts and errors inherent to different isolation/extraction procedures. Pitfalls frequently noted have in the main been due to diet and/or drug metabolites with similar chromatographic behaviour to endogenous purines and pyrimidines.These problems are exaggerated in renal failure and during antibiotic therapy.
Data derived from the chromatography of body fluids of patients with various purine and pyrimidine defects,illustrate the adaptability of the system. The method is particularly applicable to the separation of endogenously derived adenosine based compounds. An abbreviated form of the system has been used quccessfully for enzyme assays and other in vitro studies. Ste. Justine, Montreal.
5-AZA-CdR, ananalogue of deoxycytidine, is an effective anti leukemic agent. The antineoplastic action of 5-AZA-CdR appears to be related to the inhibition of DNA methylation. This inhibition activates gene expression and induces cellular differentiaion. The metabolism of 5-AZA-CdR is important because changes in the intracellular pool of deoxynucleotides may modulate the action of nucleoside analogs. I n fact Grant et al., (Cancer Res. 1982) have reported drug synergism between thymidine and 5-AZA-CdR inahuman premyelocytic cell line and in our experiments on L1210 cells, a correlation between 5-AZA-CdR effect and DNA methylation has been found. We have investigated the kinetic interactions of W -d C M P and its triphosphate with mammalian dCMP deaminase, an enzyme that plays an important role in deoxynucleotide metabolism by modulating the intracellular pool size of dCTP and dTTP. 5-AZA-dCMP is a substrate of the enzyme and is deaminated at a rate of about 100-fold lower than the natural substrate, dCMP. 5-AZA-dCTP is an allosteric activator which reverts the inhibitory effect of dTTP. The mechanism by which the antileukemic action of 5-AZA-CdR can be enchanced by thymidine is the inhibition of 5AZA-dCMP deamination by dTTP. 
